Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed surgery for locally advanced esophageal squamous cell carcinoma: Protocol for a multi-center, prospective, randomized-controlled, phase III clinical study (Keystone-002)

被引:0
|
作者
Jiang, H. [1 ]
Shang, X. [1 ]
Zhang, C. [1 ]
Yue, J. [1 ]
Duan, X. [1 ]
Ma, Z. [1 ]
Chen, C. [1 ]
Zhang, W. [1 ,2 ]
Pang, Q. [1 ]
Zhang, W. [1 ,2 ]
Liu, L. [2 ]
Ren, X. [2 ]
Meng, B. [3 ]
Zhao, G. [3 ]
Zhang, P. [4 ]
Wei, Y. [5 ]
Ma, Y. [6 ]
Zhang, L. [7 ]
Li, Y. [8 ]
机构
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Minimally Invas Esophageal Surg, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China
[3] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China
[4] Tianjin Med Univ, Gen Hosp, Dept Thorac Surg, Tianjin, Peoples R China
[5] Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao, Peoples R China
[6] Liaoning Canc Hosp, Dept Thorac Surg, Shenyang, Peoples R China
[7] Shandong First Med Univ, Shandong Prov Hosp, Dept Thorac Surg, Jinan, Peoples R China
[8] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Thorac Surg Oncol, Beijing, Peoples R China
关键词
D O I
10.1016/j.annonc.2021.10.185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
166TiP
引用
收藏
页码:S1454 / S1455
页数:2
相关论文
共 50 条
  • [31] A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump ≥4 cm)
    Li, F.
    Li, J.
    Yin, S.
    Mei, F.
    Du, Y.
    Hu, L.
    Tian, X.
    Hong, W.
    Shan, L.
    Liu, M.
    Chen, Y.
    Mao, W.
    Mu, J.
    Lu, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E616 - E616
  • [32] Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: Neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy
    Stuschke, M
    Stahl, M
    Wilke, H
    Walz, MK
    Seeber, S
    Klump, B
    Budach, W
    Becker, H
    Haeussinger, D
    Schmitt, G
    Roeher, HD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S139 - S139
  • [33] Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy
    Stuschke, M
    Stahl, M
    Wilke, H
    Walz, M
    Seeber, S
    Klump, B
    Budach, W
    Becker, H
    Schmitt, G
    Roeher, H
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S148 - S148
  • [34] Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma A Randomized Clinical Trial
    Wang, Hao
    Tang, Han
    Fang, Yong
    Tan, Lijie
    Yin, Jun
    Shen, Yaxing
    Zeng, Zhaochong
    Zhu, Jiangyi
    Hou, Yingyong
    Du, Ming
    Jiao, Jia
    Jiang, Hongjing
    Gong, Lei
    Li, Zhigang
    Liu, Jun
    Xie, Deyao
    Li, Wenfeng
    Lian, Changhong
    Zhao, Qiang
    Chen, Chun
    Zheng, Bin
    Liao, Yongde
    Li, Kuo
    Li, Hecheng
    Wu, Han
    Dai, Liang
    Chen, Ke-Neng
    JAMA SURGERY, 2021, 156 (05) : 444 - 451
  • [35] Phase II randomized study comparing concurrent chemoradiation versus neoadjuvant chemotherapy followed by chemoradiation in locally advanced unresectable squamous cell carcinoma of esophagus.
    Chaudhari, Pritee Baburao
    Chander, Subhash
    Mohanti, B. K.
    Sharma, Atul
    Kaur, Jaspreet
    Pathy, Sushmita
    Deo, S. V. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol
    Engineer, Reena
    Patkar, Shraddha
    Lewis, Shirley Christabel
    Das Sharma, Ashutosh
    Shetty, Nitin
    Ostwal, Vikas
    Ramaswamy, Anant
    Chopra, Supriya
    Agrawal, Archi
    Patil, Prachi
    Mehta, Shaesta
    Goel, Mahesh
    BMJ OPEN, 2019, 9 (06):
  • [37] Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason Chia-Hsien
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [38] Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma
    Fan, Yun
    Jiang, Youhua
    Zhou, Xinming
    Chen, Qixun
    Huang, Zhiyu
    Xu, Yanjun
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Liu, Jinshi
    Lei, Tao
    Zhao, Qiang
    Mao, Weimin
    ONCOTARGET, 2016, 7 (31) : 50624 - 50634
  • [39] Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial
    Zhan, Mei
    Zheng, Hanrui
    Yang, Yu
    Xu, Ting
    Li, Qiu
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 27 - 32
  • [40] A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Zhang, Mang
    Chen, Yu
    Wu, Weili
    Jin, Feng
    Li, Yuanyuan
    Long, Jinhua
    Luo, Xiuling
    Gong, Xiuyun
    Chen, Xiaoxiao
    Liu, Lina
    Tang, Hong
    Wang, Ziqi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (20) : 18039 - 18064